aHUS

GPTKB entity

Statements (48)
Predicate Object
gptkbp:instanceOf gptkb:disease
gptkbp:abbreviation gptkb:atypical_hemolytic_uremic_syndrome
gptkbp:affects blood
kidneys
gptkbp:associatedWith gptkb:CFI
gptkb:CD46
gptkb:CFH
gptkb:DGKE
gptkb:THBD
gptkb:CFB
C3
gptkbp:category gptkb:thrombotic_microangiopathy
gptkbp:cause genetic disorder
autoimmune response
complement system dysregulation
gptkbp:causedBy Shiga toxin-producing E. coli
gptkbp:complication hypertension
chronic kidney disease
end-stage renal disease
gptkbp:diagnosedBy blood test
kidney biopsy
gptkbp:differentialDiagnosis gptkb:typical_hemolytic_uremic_syndrome
thrombotic thrombocytopenic purpura
gptkbp:field nephrology
hematology
gptkbp:firstDescribed 1955
gptkbp:fullName gptkb:atypical_hemolytic_uremic_syndrome
https://www.w3.org/2000/01/rdf-schema#label aHUS
gptkbp:ICD-10_code D59.3
gptkbp:inheritance autosomal dominant
autosomal recessive
gptkbp:mortalityRate high without treatment
gptkbp:OMIM 235400
gptkbp:onset any age
gptkbp:prevalence rare
gptkbp:riskFactor certain medications
infection
pregnancy
genetic predisposition
gptkbp:symptom gptkb:anemia
thrombocytopenia
acute kidney injury
gptkbp:treatment gptkb:eculizumab
gptkb:ravulizumab
supportive care
plasma exchange
gptkbp:bfsParent gptkb:atypical_hemolytic_uremic_syndrome
gptkbp:bfsLayer 8